Temporomandibular Joint Disorders
Conditions
Interventions
This is a pilot, open-label, single-arm clinical trial. Study group: 10 patients, men and women aged between 18 and 70 years, diagnosed with bruxism for more than five years, who are indicated for bru
Sponsors
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Male and female patients. Age range between 18 and 70 years old. Report of severe bruxism. Who do or do not use myorelaxing interocclusion plates
Exclusion criteria
Exclusion criteria: Patients with mild bruxism. Patients with bruxism in sporadic situations. Patients reporting allergies to lidocaine. Patients with skin lesions on the face
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in pain, assessed by Visual Analogue Scale – VAS, to at least moderate pain. Data collected before treatment and at the end of treatment, 30 days;The transposition of a 5% lidocaine patch as an adjuvant treatment for patients with severe or moderate sleep bruxism provided muscle relaxation, with a reduction in orofacial pain, good acceptance and improved sleep quality without causing adverse reactions. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactMarli Gerenutti
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Outcome results
None listed